Jeffrey E. Young, Chief Financial Officer at OvaScience, Inc. (OVAS), bought 300 shares at $29.93 ($9K) on 2015-04-08, disclosed to the SEC on 2015-04-09.
Open-market purchase of $9k OVAS by Chief Financial Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.